Search
for
Sort by
Research 31–60 of 197
- Neonatal lupus syndrome in a Nigerian child
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Skin amidst COVID ‐19 pandemic
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- The Skin and Subcutaneous Tissues
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Delicious Dermatology: Baked-Up Eponyms
- A concomitant diagnosis of COVID‐19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report
- Cutaneous extramedullary haematopoiesis: Implications in human disease and treatment
- The COVID-19 pandemic and its skin effects
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Rumpel-Leede Phenomenon Associated with Pneumatic Compression: A Case Report
- Cutaneous manifestations associated with substance use disorders
- The Spectrum of Skin Disease Among Indian Children
- Fatal Toxic Epidermal Necrolysis Associated with Minoxidil
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study
- Self-Assessment
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Dermatological Manifestations of COVID-19 Patients
- Drug-Induced Skin, Nail and Hair Disorders
- Cutaneous lupus erythematosus
- Psychoactive drugs and skin
- Dermoscopy: not just for dermatologists